The process of Tumor necrosis factor-α (TNF-α)-induced epithelial-to-mesenchymal de-differentiation was shown to lead to a loss of neoantigens causing transformation to a tumor phenotype that is less immunogenic and can more readily evade immune surveillance in the ACT-treated mouse model in melanoma (122). The gene discussed is TNF; the disease is melanoma.